Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Rectal Cancer treatment details. Chemotherapy. Korea University Medical Center, Seoul, Korea



Survival: 5.3 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs:
Country: Korea
   
City/State/Province: Seoul
   
Hospital: Korea University Medical Center
   
Journal: Link
   
Date: 3/2011

Description:
Patients:
This study involved 20 patients with metastatic colorectal cancer whose disease had progressed following previous FOLFOX and FOLFIRI chemotherapy regimens.

Treatment:
Patients were administered the chemotherapy agent capecitabine.

Toxicity:
The maximum reported toxicity was 1 case of grade 3-4 hand-foot syndrome (skin irritation on hands and feet). Grade 2 mucositis (inflammation of the mouth and GI tract) was also reported.

Results:
The median progression-free survival was 2.3 months and the median overall survival was 5.3 months.

Correspondence: Dr. Yeul Hong Kim

E-mail to a Friend Email Physician More Information